Endocannabinoid signaling regulates sleep stability

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Pava, Matthew J ^a   Makriyannis, Alexandros ^b   Lovinger, David M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 4 [BIS(1,3 BENZODIOXOL 5 YL)HYDROXYMETHYL] 1 PIPERIDINECARBOXYLIC ACID 4 NITROPHENYL ESTER; AM 3506; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CP 47497; ENDOCANNABINOID; ENZYME INHIBITOR; FATTY ACID AMIDASE; MONOACYGLYCEROL LIPASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; ACYLGLYCEROL LIPASE; AMIDASE; FATTY-ACID AMIDE HYDROLASE; MORPHOLINE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ALERTNESS; ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; GAMMA RHYTHM; MALE; MOUSE; NONHUMAN; NONREM SLEEP; POLYSOMNOGRAPHY; REGULATORY MECHANISM; SCORING SYSTEM; SLEEP; SLEEP DEPRIVATION; VALIDATION STUDY; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; ELECTRODE IMPLANT; ELECTROENCEPHALOGRAPHY; INVERSE AGONISM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REM SLEEP; SIGNAL TRANSDUCTION;

ALGORITHMS; AMIDOHYDROLASES; ANIMALS; BENZODIOXOLES; DRUG INVERSE AGONISM; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; MALE; MICE; MICE, INBRED C57BL; MONOACYLGLYCEROL LIPASES; MORPHOLINES; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SLEEP; SLEEP DEPRIVATION; SLEEP, REM;

EID: 84977642916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152473     Document Type: Article

References (86)

1. Russo E. Cannabis in India: ancient lore and modern medicine. In: Mechoulam R, editor. Cannabinoids as Therapeutics. Milestones in drug therapy. Basel; Boston: Birkhäuser; 2005. p. 1-22.
2. O'Shaughnessy WB. On the Preparations of the Indian Hemp, or Gunjah: Cannabis Indica Their Effects on the Animal System in Health, and their Utility in the Treatment of Tetanus and other Convulsive Diseases. Prov Med J Retrosp Med Sci. 1843; 5(123):363-9. PubMed Central PMCID: PMCPMC2490264.
3. Wallich GC. Cannabis Indica. Br Med J. 1883; 1(1173):1224. PMID: 20750654.
4. Bradbury JB. The Croonian Lectures on some Points Connected with Sleep, Sleeplessness, and Hypnotics: Delivered before the Royal College of Physicians of London. Br Med J. 1899; 2(2011):134-8. PMID: 20758585.
5. Clendinning J. Observations on the medicinal properties of the Cannabis Sativa of India. Medico-chirurgical transactions. 1843; 26:188-210. PMC2116906. PMID: 20895771
6. Moreton JE, Davis WM. Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat. Neuropharmacology. 1973; 12(9):897-907. Epub 1973/09/01. PMID: 4355678.
7. Watanabe K, Narimatsu S, Yamamoto I, Yoshimura H. Difference in tolerance development of hypothermia and pentobarbital-induced sleep prolongating effect of 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol in mice. European journal of pharmacology. 1982; 77(1):53-6. Epub 1982/01/08. PMID: 6277654.
8. Watanabe K, Narimatsu S, Yamamoto I, Yoshimura H. Cross-tolerance development to the prolongation of pentobarbitone-induced sleep by delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice. The Journal of pharmacy and pharmacology. 1987; 39(11):945-7. Epub 1987/11/01. PMID: 2892923.
9. Zarcone VP Jr. Marijuana and ethanol: effects on sleep. Int J Psychiatry Med. 1973; 4(2):201-12. PMID: 4352042.
10. Fujimori M, Himwich HE. Delta 9-tetrahydrocannabinol and the sleep-wakefulness cycle in rabbits. Physiology & behavior. 1973; 11(3):291-5. Epub 1973/09/01. PMID: 4355439.
11. Wallach MB, Gershon S. The effects of delta8-THC on the EEG, reticular multiple unit activity and sleep of cats. European journal of pharmacology. 1973; 24(2):172-8. PMID: 4358207.
12. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev. 2009; 89(1):309-80. doi: 10.1152/physrev.00019.2008 PMID: 19126760.
13. Murillo-Rodriguez E, Cabeza R, Mendez-Diaz M, Navarro L, Prospero-Garcia O. Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. Neuroreport. 2001; 12(10):2131-6. Epub 2001/07/12. PMID: 11447321.
14. Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D, Drucker-Colin R, Prospero-Garcia O. Anandamide modulates sleep and memory in rats. Brain research. 1998; 812(1-2):270-4. Epub 1998/11/14. PMID: 9813364.
15. Murillo-Rodriguez E, Blanco-Centurion C, Sanchez C, Piomelli D, Shiromani PJ. Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep. 2003; 26(8):943-7. Epub 2004/01/30. PMID: 14746372.
16. Rueda-Orozco PE, Soria-Gomez E, Montes-Rodriguez CJ, Perez-Morales M, Prospero-Garcia O. Intrahippocampal administration of anandamide increases REM sleep. Neuroscience letters. 2010; 473(2):158-62. Epub 2010/03/02. doi: 10.1016/j.neulet.2010.02.044 PMID: 20188142.
17. Murillo-Rodriguez E, Palomero-Rivero M, Millan-Aldaco D, Arias-Carrion O, Drucker-Colin R. Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. PloS one. 2011; 6(7):e20766. doi: 10.1371/journal.pone.0020766 PMID: 21779318; PubMed Central PMCID: PMC3136458.
18. Murillo-Rodriguez E, Vazquez E, Millan-Aldaco D, Palomero-Rivero M, Drucker-Colin R. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat. European journal of pharmacology. 2007; 562(1-2):82-91. Epub 2007/03/06. doi: 10.1016/j.ejphar.2007.01.076 PMID: 17336288.
19. Murillo-Rodriguez E, Millan-Aldaco D, Di Marzo V, Drucker-Colin R. The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. Neuroscience. 2008; 157(1):1-11. Epub 2008/09/30. doi: 10.1016/j.neuroscience.2008.08.056 PMID: 18822353.
20. Murillo-Rodriguez E, Palomero-Rivero M, Millan-Aldaco D, Di Marzo V. The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats. Physiology & behavior. 2013; 109:88-95. Epub 2012/12/15. doi: 10.1016/j.physbeh.2012.11.007 PMID: 23238438.
21. Huitron-Resendiz S, Sanchez-Alavez M, Wills DN, Cravatt BF, Henriksen SJ. Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. Sleep. 2004; 27(5):857-65. PMID: 15453543.
22. Nathan PJ, O'Neill BV, Napolitano A, Bullmore ET. Neuropsychiatric adverse effects of centrally acting antiobesity drugs. CNS Neurosci Ther. 2011; 17(5):490-505. doi: 10.1111/j.1755-5949.2010.00172.x PMID: 21951371.
23. Steinberg BA, Cannon CP. Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential. Am J Cardiol. 2007; 100(12A):27P-32P. doi: 10.1016/j.amjcard.2007.10.011 PMID: 18154743.
24. Pava MJ, den Hartog CR, Blanco-Centurion C, Shiromani PJ, Woodward JJ. Endocannabinoid modulation of cortical up-states and NREM sleep. PloS one. 2014; 9(2):e88672. Epub 2014/02/13. doi: 10.1371/journal.pone.0088672 PMID: 24520411; PubMed Central PMCID: PMC3919802.
25. Silvani A, Berteotti C, Bastianini S, Lo Martire V, Mazza R, Pagotto U, et al. Multiple sleep alterations in mice lacking cannabinoid type 1 receptors. PloS one. 2014; 9(2):e89432. Epub 2014/03/04. doi: 10.1371/journal.pone.0089432 PMID: 24586776; PubMed Central PMCID: PMC3930731.
26. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96(10):5780-5. PMID: 10318961; PubMed Central PMCID: PMCPMC21937.
27. Wu CS, Zhu J, Wager-Miller J, Wang S, O'Leary D, Monory K, et al. Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. The European journal of neuroscience. 2010; 32(5):693-706. doi: 10.1111/j.1460-9568.2010.07337.x PMID: 21050275; PubMed Central PMCID: PMCPMC2970673.
28. Santucci V, Storme JJ, Soubrie P, Le Fur G. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleepwaking cycle analysis. Life sciences. 1996; 58(6):PL103-10. Epub 1996/01/01. PMID: 8569415.
29. Goonawardena AV, Plano A, Robinson L, Ross R, Greig I, Pertwee RG, et al. Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459. Behav Pharmacol. 2015; 26(3):289-303. doi: 10.1097/FBP.0000000000000108 PMID: 25356730; PubMed Central PMCID: PMC4445652.
30. Perez-Morales M, Alvarado-Capuleno I, Lopez-Colome AM, Mendez-Diaz M, Ruiz-Contreras AE, Prospero-Garcia O. Activation of PAR1 in the lateral hypothalamus of rats enhances food intake and REMS through CB1R. Neuroreport. 2012; 23(14):814-8. Epub 2012/08/15. doi: 10.1097/WNR.0b013e328357615a PMID: 22889888.
31. Mendelson WB, Basile AS. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. Neuroreport. 1999; 10(15):3237-9. PMID: 10574567.
32. Goonawardena AV, Plano A, Robinson L, Platt B, Hampson RE, Riedel G. A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats. Sleep disorders. 2011; 2011:178469. Epub 2011/01/01. doi: 10.1155/2011/178469 PMID: 23471192; PubMed Central PMCID: PMC3581240.
33. Liedhegner ES, Sasman A, Hillard CJ. Brain region-specific changes in N-acylethanolamine contents with time of day. J Neurochem. 2014; 128(4):491-506. doi: 10.1111/jnc.12495 PMID: 24138639; PubMed Central PMCID: PMC3946166.
34. Valenti M, Vigano D, Casico MG, Rubino T, Steardo L, Parolaro D, et al. Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell Mol Life Sci. 2004; 61(7-8):945-50. doi: 10.1007/s00018-003-3453-5 PMID: 15095014.
35. National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, National Academies Press. Guide for the care and use of laboratory animals. 8th ed. Washington, D.C.: National Academies Press; 2011. xxv, 220 p. p.
36. Gervasoni D, Lin SC, Ribeiro S, Soares ES, Pantoja J, Nicolelis MA. Global forebrain dynamics predict rat behavioral states and their transitions. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2004; 24(49):11137-47. Epub 2004/12/14. doi: 10.1523/JNEUROSCI.3524-04.2004 PMID: 15590930.
37. Mang GM, Franken P. Sleep and EEG Phenotyping in Mice. Curr Protoc Mouse Biol. 2012; 2(1):55-74. doi: 10.1002/9780470942390.mo110126 PMID: 26069005.
38. Diniz Behn CG, Klerman EB, Mochizuki T, Lin SC, Scammell TE. Abnormal sleep/wake dynamics in orexin knockout mice. Sleep. 2010; 33(3):297-306. PMID: 20337187; PubMed Central PMCID: PMCPMC2831423.
39. Bastianini S, Berteotti C, Gabrielli A, Del Vecchio F, Amici R, Alexandre C, et al. SCOPRISM: a new algorithm for automatic sleep scoring in mice. J Neurosci Methods. 2014; 235:277-84. doi: 10.1016/j.jneumeth.2014.07.018 PMID: 25092499.
40. Weber F, Chung S, Beier KT, Xu M, Luo L, Dan Y. Control of REM sleep by ventral medulla GABAergic neurons. Nature. 2015; 526(7573):435-8. doi: 10.1038/nature14979 PMID: 26444238.
41. Srinivasan BV, Qi H, Duraiswami R. GPUML: Graphical processors for speeding up kernel machines. Siam Conference on Data Mining; April 2010; Columbus, OH2010.
42. Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? British journal of pharmacology. 2010; 160(3):530-43. Epub 2010/07/02. doi: 10.1111/j.1476-5381.2010.00790.x PMID: 20590563; PubMed Central PMCID: PMC2931554.
43. Vyazovskiy VV, Riedner BA, Cirelli C, Tononi G. Sleep homeostasis and cortical synchronization: II. A local field potential study of sleep slow waves in the rat. Sleep. 2007; 30(12):1631-42. PMID: 18246973; PubMed Central PMCID: PMCPMC2276140.
44. Borbely AA, Achermann P. Sleep homeostasis and models of sleep regulation. J Biol Rhythms. 1999; 14(6):557-68. PMID: 10643753.
45. Kim T, Ramesh V, Dworak M, Choi DS, McCarley RW, Kalinchuk AV, et al. Disrupted sleep-wake regulation in type 1 equilibrative nucleoside transporter knockout mice. Neuroscience. 2015; 303:211-9. doi: 10.1016/j.neuroscience.2015.06.037 PMID: 26143012; PubMed Central PMCID: PMCPMC4532636.
46. Jacobs J. Hippocampal theta oscillations are slower in humans than in rodents: implications for models of spatial navigation and memory. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1635):20130304. doi: 10.1098/rstb.2013.0304 PMID: 24366145; PubMed Central PMCID: PMCPMC3866455.
47. Fries P. Neuronal gamma-band synchronization as a fundamental process in cortical computation. Annu Rev Neurosci. 2009; 32:209-24. doi: 10.1146/annurev.neuro.051508.135603 PMID: 19400723.
48. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, et al. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther. 2005; 313(1):352-8. doi: 10.1124/jpet.104.078980 PMID: 15579492.
49. Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry. 2013; 18(7):813-23. doi: 10.1038/mp.2012.72 PMID: 22688188; PubMed Central PMCID: PMC3549323.
50. Dijk DJ, Brunner DP, Beersma DG, Borbely AA. Electroencephalogram power density and slow wave sleep as a function of prior waking and circadian phase. Sleep. 1990; 13(5):430-40. PMID: 2287855.
51. Borbely AA. A two process model of sleep regulation. Hum Neurobiol. 1982; 1(3):195-204. PMID: 7185792.
52. Dzirasa K, Ribeiro S, Costa R, Santos LM, Lin SC, Grosmark A, et al. Dopaminergic control of sleep-wake states. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2006; 26(41):10577-89. doi: 10.1523/JNEUROSCI.1767-06.2006 PMID: 17035544.
53. Lin SC, Gervasoni D. Defining Global Brain States Using Multielectrode Field Potential Recordings. In:Nicolelis MAL, editor. Methods for Neural Ensemble Recordings. Frontiers in Neuroscience. 2nd ed. Boca Raton (FL)2008.
54. Sunagawa GA, Sei H, Shimba S, Urade Y, Ueda HR. FASTER: an unsupervised fully automated sleep staging method for mice. Genes to cells: devoted to molecular & cellular mechanisms. 2013; 18(6):502-18. doi: 10.1111/gtc.12053 PMID: 23621645; PubMed Central PMCID: PMC3712478.
55. Savinainen JR, Jarvinen T, Laine K, Laitinen JT. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. British journal of pharmacology. 2001; 134(3):664-72. doi: 10.1038/sj.bjp.0704297 PMID: 11588122; PubMed Central PMCID: PMCPMC1572991.
56. Melvin LS, Milne GM, Johnson MR, Subramaniam B, Wilken GH, Howlett AC. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Mol Pharmacol. 1993; 44(5):1008-15. PMID: 8246904.
57. Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther. 1992; 260(1):201-9. PMID: 1309872.
58. Mackie K, Devane WA, Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol. 1993; 44(3):498-503. PMID: 8371711.
59. Garzon J, de la Torre-Madrid E, Rodriguez-Munoz M, Vicente-Sanchez A, Sanchez-Blazquez P. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. Mol Pain. 2009; 5:11. doi: 10.1186/1744-8069-5-11 PMID: 19284549; PubMed Central PMCID: PMC2657119.
60. Zhuang S, Kittler J, Grigorenko EV, Kirby MT, Sim LJ, Hampson RE, et al. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions. Brain Res Mol Brain Res. 1998; 62(2):141-9. PMID: 9813289.
61. Martinez-Vargas M, Morales-Gomez J, Gonzalez-Rivera R, Hernandez-Enriquez C, Perez-Arredondo A, Estrada-Rojo F, et al. Does the neuroprotective role of anandamide display diurnal variations? Int J Mol Sci. 2013; 14(12):23341-55. doi: 10.3390/ijms141223341 PMID: 24287910; PubMed Central PMCID: PMCPMC3876049.
62. Yasuo S, Koch M, Schmidt H, Ziebell S, Bojunga J, Geisslinger G, et al. An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes. Cell Tissue Res. 2010; 340(1):127-36. doi: 10.1007/s00441-010-0930-7 PMID: 20165884.
63. Acuna-Goycolea C, Obrietan K, van den Pol AN. Cannabinoids excite circadian clock neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2010; 30(30):10061-6. doi: 10.1523/JNEUROSCI.5838-09.2010 PMID: 20668190; PubMed Central PMCID: PMCPMC2927117.
64. Sanford AE, Castillo E, Gannon RL. Cannabinoids and hamster circadian activity rhythms. Brain research. 2008; 1222:141-8. doi: 10.1016/j.brainres.2008.05.048 PMID: 18582849.
65. Davis CJ, Clinton JM, Jewett KA, Zielinski MR, Krueger JM. Delta wave power: an independent sleep phenotype or epiphenomenon? J Clin Sleep Med. 2011; 7(5 Suppl):S16-8. doi: 10.5664/JCSM.1346 PMID: 22003323; PubMed Central PMCID: PMC3190419.
66. Baud MO, Magistretti PJ, Petit JM. Sustained sleep fragmentation induces sleep homeostasis in mice. Sleep. 2015; 38(4):567-79. doi: 10.5665/sleep.4572 PMID: 25325477; PubMed Central PMCID: PMCPMC4355896.
67. He J, Kastin AJ, Wang Y, Pan W. Sleep fragmentation has differential effects on obese and lean mice. J Mol Neurosci. 2015; 55(3):644-52. doi: 10.1007/s12031-014-0403-7 PMID: 25152064; PubMed Central PMCID: PMC4320048.
68. Ringgold KM, Barf RP, George A, Sutton BC, Opp MR. Prolonged sleep fragmentation of mice exacerbates febrile responses to lipopolysaccharide. J Neurosci Methods. 2013; 219(1):104-12. doi: 10.1016/j.jneumeth.2013.07.008 PMID: 23872243; PubMed Central PMCID: PMC3993011.
69. Hajos M, Hoffmann WE, Kocsis B. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry. 2008; 63(11):1075-83. doi: 10.1016/j.biopsych.2007.12.005 PMID: 18261715.
70. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. The European journal of neuroscience. 2000; 12(9):3239-49. PMID: 10998107.
71. Kucewicz MT, Tricklebank MD, Bogacz R, Jones MW. Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2011; 31(43):15560-8. doi: 10.1523/JNEUROSCI.2970-11.2011 PMID: 22031901.
72. Cortes-Briones J, Skosnik PD, Mathalon D, Cahill J, Pittman B, Williams A, et al. Delta(9)-THC Disrupts Gamma (gamma)-Band Neural Oscillations in Humans. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2015; 40(9):2124-34. doi: 10.1038/npp.2015.53 PMID: 25709097.
73. Robbe D, Montgomery SM, Thome A, Rueda-Orozco PE, McNaughton BL, Buzsaki G. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci. 2006; 9(12):1526-33. doi: 10.1038/nn1801 PMID: 17115043.
74. Buonamici M, Young GA, Khazan N. Effects of acute delta 9-THC administration on EEG and EEG power spectra in the rat. Neuropharmacology. 1982; 21(8):825-9. PMID: 6289162.
75. Sales-Carbonell C, Rueda-Orozco PE, Soria-Gomez E, Buzsaki G, Marsicano G, Robbe D. Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(2):719-24. Epub 2012/12/28. doi: 10.1073/pnas.1217144110 PMID: 23269835; PubMed Central PMCID: PMC3545808.
76. Turkanis SA, Karler R. Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats. Neuropharmacology. 1982; 21(1):7-13. PMID: 6278353.
77. Kim D, Hwang E, Lee M, Sung H, Choi JH. Characterization of topographically specific sleep spindles in mice. Sleep. 2015; 38(1):85-96. doi: 10.5665/sleep.4330 PMID: 25325451; PubMed Central PMCID: PMCPMC4262960.
78. Ryan LJ. Characterization of cortical spindles in DBA/2 and C57BL/6 inbred mice. Brain Res Bull. 1984; 13(4):549-58. PMID: 6441615.
79. Perez-Morales M, De La Herran-Arita AK, Mendez-Diaz M, Ruiz-Contreras AE, Drucker-Colin R, Prospero-Garcia O. 2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. Pharmacology, biochemistry, and behavior. 2013; 108:1-7. Epub 2013/04/23. doi: 10.1016/j.pbb.2013.04.006 PMID: 23603032.
80. Jacobson LH, Commerford SR, Gerber SP, Chen YA, Dardik B, Chaperon F, et al. Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity. Naunyn-Schmiedeberg's archives of pharmacology. 2011; 384(6):565-81. Epub 2011/09/29. doi: 10.1007/s00210-011-0686-y PMID: 21947251.
81. Feinberg I, Jones R, Walker J, Cavness C, Floyd T. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Clin Pharmacol Ther. 1976; 19(6):782-94. PMID: 178475.
82. Ceccarini J, Kuepper R, Kemels D, van Os J, Henquet C, Van Laere K. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addict Biol. 2015; 20(2):357-67. doi: 10.1111/adb.12116 PMID: 24373053.
83. Sim LJ, Hampson RE, Deadwyler SA, Childers SR. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1996; 16(24):8057-66. PMID: 8987831.
84. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, D.C.: American Psychiatric Association; 2013. xliv, 947 p. p.
85. Gates P, Albertella L, Copeland J. Cannabis withdrawal and sleep: A systematic review of human studies. Subst Abus. 2015: 0. doi: 10.1080/08897077.2015.1023484 PMID: 25893849.
86. Fernandez-Mendoza J, Shea S, Vgontzas AN, Calhoun SL, Liao D, Bixler EO. Insomnia and incident depression: role of objective sleep duration and natural history. J Sleep Res. 2015; 24(4):390-8. doi: 10.1111/jsr.12285 PMID: 25728794.